围手术期常规给予酮咯酸与小儿神经外科手术患者的出血无关。

Routine perioperative ketorolac administration is not associated with hemorrhage in pediatric neurosurgery patients.

作者信息

Richardson Marlin Dustin, Palmeri Nicholas O, Williams Sarah A, Torok Michelle R, O'Neill Brent R, Handler Michael H, Hankinson Todd C

机构信息

Department of Neurosurgery and.

College of Physicians and Surgeons, Columbia University, New York, New York;

出版信息

J Neurosurg Pediatr. 2016 Jan;17(1):107-15. doi: 10.3171/2015.4.PEDS14411. Epub 2015 Oct 9.

Abstract

OBJECT NSAIDs are effective perioperative analgesics. Many surgeons are reluctant to use NSAIDs perioperatively because of a theoretical increase in the risk for bleeding events. The authors assessed the effect of routine perioperative ketorolac use on intracranial hemorrhage in children undergoing a wide range of neurosurgical procedures. METHODS A retrospective single-institution analysis of 1451 neurosurgical cases was performed. Data included demographics, type of surgery, and perioperative ketorolac use. Outcomes included bleeding events requiring return to the operating room, bleeding seen on postoperative imaging, and the development of renal failure or gastrointestinal tract injury. Variables associated with both the exposure and outcomes (p < 0.20) were evaluated as potential confounders for bleeding on postoperative imaging, and multivariable logistic regression was performed. Bivariable analysis was performed for bleeding events. Odds ratios and 95% CIs were estimated. RESULTS Of the 1451 patients, 955 received ketorolac. Multivariate regression analysis demonstrated no significant association between clinically significant bleeding events (OR 0.69; 95% CI 0.15-3.1) or radiographic hemorrhage (OR 0.81; 95% CI 0.43-1.51) and the perioperative administration of ketorolac. Treatment with a medication that creates a known bleeding risk (OR 3.11; 95% CI 1.01-9.57), surgical procedure (OR 2.35; 95% CI 1.11-4.94), and craniotomy/craniectomy (OR 2.43; 95% CI 1.19-4.94) were associated with a significantly elevated risk for radiographically identified hemorrhage. CONCLUSIONS Short-term ketorolac therapy does not appear to be associated with a statistically significant increase in the risk of bleeding documented on postoperative imaging in pediatric neurosurgical patients and may be considered as part of a perioperative analgesic regimen. Although no association was found between ketorolac and clinically significant bleeding events, a larger study needs to be conducted to control for confounding factors, because of the rarity of these events.

摘要

目的

非甾体抗炎药(NSAIDs)是有效的围手术期镇痛药。由于理论上出血事件风险增加,许多外科医生不愿在围手术期使用NSAIDs。作者评估了围手术期常规使用酮咯酸对接受各种神经外科手术的儿童颅内出血的影响。

方法

对1451例神经外科病例进行单机构回顾性分析。数据包括人口统计学、手术类型和围手术期酮咯酸使用情况。结果包括需要返回手术室的出血事件、术后影像学检查发现的出血以及肾衰竭或胃肠道损伤的发生。将与暴露和结果均相关(p<0.20)的变量评估为术后影像学检查出血的潜在混杂因素,并进行多变量逻辑回归分析。对出血事件进行双变量分析。估计比值比和95%可信区间。

结果

1451例患者中,955例接受了酮咯酸治疗。多变量回归分析显示,临床显著出血事件(比值比0.69;95%可信区间0.15-3.1)或影像学出血(比值比0.81;95%可信区间0.43-1.51)与围手术期使用酮咯酸之间无显著关联。使用已知有出血风险的药物进行治疗(比值比3.11;95%可信区间1.01-9.57)、手术操作(比值比2.35;95%可信区间1.11-4.94)以及开颅手术/颅骨切除术(比值比2.43;95%可信区间1.19-4.94)与影像学确定的出血风险显著升高相关。

结论

短期酮咯酸治疗似乎与小儿神经外科患者术后影像学检查记录的出血风险在统计学上无显著增加相关,可考虑作为围手术期镇痛方案的一部分。尽管未发现酮咯酸与临床显著出血事件之间存在关联,但由于这些事件罕见,需要进行更大规模的研究以控制混杂因素。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索